STAT3 and cancer: The dysregulation of the STAT3 signaling pathway has been associated with the development and progression of various diseases, including cancer, autoimmune, inflammatory, and neurological disorders.[31] IL-6 can promote the differentiation of B cells and activation of T cells, enhance acute inflammatory responses, and regulate the hepatic synthesis of acute-phase proteins.